Ozempic (semaglutide) and Victoza (liraglutide) are prescription drugs used to treat type 2 diabetes and reduce the risk of cardiovascular problems. Both drugs come as an injection. Ozempic is not ...

The treatments, which include medications like semaglutide, liraglutide and exenatide, have been linked to a slightly reduced dementia risk before, but this was based on observational studies ...

formulation in form of orally dispersible films allows absorption of sublingually administrated peptides such as GLP-1 (Semaglutide, Liraglutide etc.). The new formulation is expected to offer ...

Oral semaglutide demonstrated superior cardiometabolic outcomes relative to placebo and active comparators, including empaglifozin, in T2D.

Semaglutide (the active ingredient in Ozempic ... A study published earlier this January, for instance, found some evidence that liraglutide (an older GLP-1 drug) could reduce the rate of brain ...

researchers looked at how GLP-1 receptor agonists — drugs like semaglutide, dulaglutide and liraglutide, which are sold as Ozempic, Trulicity and Victoza, respectively — impacted dementia risk ...